Vimarsana
Biggest News Aggregation in the World

Call Dial In News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Call Dial In. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Call Dial In Today - Breaking & Trending Today

BrainsWay to Report First Quarter 2024 Financial Results on May 8, 2024 - Vimarsana News

BrainsWay to Report First Quarter 2024 Financial Results on May 8, 2024

BURLINGTON, Mass. and JERUSALEM, April 24, 2024 -- BrainsWay Ltd. , a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it will...

LSI Industries Acquires EMI Industries, Expanding Store Fixtures and Food Service Equipment Business - Vimarsana News

LSI Industries Acquires EMI Industries, Expanding Store Fixtures and Food Service Equipment Business

LSI Acquires EMI Industries for $50 Million in Accretive, All-Cash Transaction Transaction Expands Display Solutions Capabilities Within Grocery, Convenience Store & Restaurant Markets LSI to...

Community Bank System Announces First Quarter 2024 Earnings Conference Call - Vimarsana News

Community Bank System Announces First Quarter 2024 Earnings Conference Call

SYRACUSE, N.Y., March 25, 2024 -- Community Bank System, Inc. invites you to participate in a conference call to discuss the Company’s financial and operating performance during its first...

PolyPid Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results - Vimarsana News

PolyPid Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results

More Than 100 Patients Enrolled in Ongoing SHIELD II Phase 3 Trial of D-PLEX100 for the Prevention of Abdominal Colorectal Surgical Site Infections Unblinded Interim Analysis to be Conducted Once Approximately 400 Patients Complete Their 30-Day Follow-up; Top-line Results Expected in Second Half of 2024 New Preclinical Data Showed OncoPLEX Injected Intratumorally Reduced Tumor Volume and Improved Survival in New Animal Models Recent Successful $16 Million Financing Extends Company’s Cash Runway

Source: yahoo.com
Lesaka delivers improved profitability as it exceeds FY24 Q2 guidance - Vimarsana News

Lesaka delivers improved profitability as it exceeds FY24 Q2 guidance

JOHANNESBURG, South Africa, Feb. 06, 2024 -- Lesaka Technologies, Inc. today released results for the second quarter ended December 31, 2023 . Performance Highlights for Q2 2024: Revenue of...